Company Filing History:
Years Active: 2021
Title: Innovations by Sangmyoun Lim
Introduction
Sangmyoun Lim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of dual function proteins. His work focuses on enhancing pharmacological efficacy and stability, which has important implications for therapeutic applications.
Latest Patents
Sangmyoun Lim holds a patent for a dual function protein comprising an FGF21 mutant protein and a pharmaceutical composition that includes this protein. The invention provides a dual function protein prepared by linking a biologically active protein and an FGF mutant protein to an Fc region of an immunoglobulin. This innovative approach results in improved pharmacological efficacy, in vivo duration, and protein stability. The dual function protein can be effectively used as a therapeutic agent for various conditions, including diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis, and cardiovascular diseases. He has 1 patent to his name.
Career Highlights
Sangmyoun Lim is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His role at the company allows him to further his research and development efforts in the field of biotechnology. His innovative work has positioned him as a key figure in the industry.
Collaborations
Sangmyoun Lim collaborates with talented individuals such as Jun Hwan Kim and Seyoung Lim. These collaborations enhance the research and development process, leading to more effective innovations in the field.
Conclusion
Sangmyoun Lim's contributions to biotechnology through his innovative patent on dual function proteins demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various health conditions.